Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Agenus Inc
(NQ:
AGEN
)
2.630
+0.190 (+7.79%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 27, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,092,455
Open
2.440
Bid (Size)
2.580 (1)
Ask (Size)
2.630 (22)
Prev. Close
2.440
Today's Range
2.420 - 2.670
52wk Range
1.250 - 3.370
Shares Outstanding
304,811,685
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Agenus to Participate in February Investor Conferences
January 26, 2023
From
Agenus Inc.
Via
Globe NewsWire
Agenus Presents Clinical Data Demonstrating Durable Responses For Colorectal Cancer Candidate
January 23, 2023
Via
Benzinga
Performance
YTD
+9.58%
+9.58%
1 Month
+21.20%
+21.20%
3 Month
+3.14%
+3.14%
6 Month
+1.94%
+1.94%
1 Year
+5.62%
+5.62%
More News
Read More
Agenus Presents Clinical Data Demonstrating Durable Responses of Botensilimab/Balstilimab Combination in Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI
January 23, 2023
From
Agenus Inc.
Via
Globe NewsWire
Looking Into Agenus's Return On Capital Employed
December 05, 2022
Via
Benzinga
Why Shares of Agenus Rose 12.5% on Friday
December 02, 2022
Via
The Motley Fool
Agenus (AGEN) Q3 2022 Earnings Call Transcript
November 08, 2022
Via
The Motley Fool
VBI Vaccines, Agenus Ink Partnership For Combination Brain Cancer Therapy
October 12, 2022
Via
Benzinga
Agenus to Participate at B Riley Securities’ 2023 Virtual Oncology Conference
January 10, 2023
From
Agenus Inc.
Via
Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
December 22, 2022
Via
Benzinga
Agenus to Present Botensilimab Data at Late-Breaking Oral Session at ASCO-GI
December 21, 2022
From
Agenus Inc.
Via
Globe NewsWire
7 Hot Stocks to Book Profits In Before 2023
December 19, 2022
Via
InvestorPlace
Agenus Data at CTOS 2022 Highlight Durable Clinical Responses of Botensilimab / Balstilimab Combination in Advanced Sarcoma
November 17, 2022
From
Agenus Inc.
Via
Globe NewsWire
Agenus to Participate at 5th Annual Evercore ISI HealthCONx Conference
November 16, 2022
From
Agenus Inc.
Via
Globe NewsWire
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
November 15, 2022
Via
Benzinga
Miniso Group, Monday.com And Other Big Gainers From Monday
November 15, 2022
Via
Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
November 14, 2022
Via
Benzinga
Agenus Data at SITC 2022 Highlight Durable Responses of Botensilimab / Balstilimab Combination in Nine Different Treatment-Resistant Cancers
November 14, 2022
From
Agenus Inc.
Via
Globe NewsWire
360 DigiTech, HUTCHMED And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 14, 2022
Via
Benzinga
Agenus Provides Corporate Update and Third Quarter 2022 Financial Report
November 08, 2022
From
Agenus Inc.
Via
Globe NewsWire
10 Best Medical Stocks Under $5
October 29, 2022
Via
Talk Markets
Agenus to Provide Corporate Update and Third Quarter 2022 Financial Report
October 25, 2022
From
Agenus Inc.
Via
Globe NewsWire
GSK’s older adult RSV vaccine candidate, containing Agenus’ QS-21 STIMULON™, shows 94.1% reduction in severe RSV disease and overall vaccine efficacy of 82.6% in pivotal trial
October 13, 2022
From
Agenus Inc.
Via
Globe NewsWire
VBI Vaccines and Agenus Announce Collaboration to Evaluate VBI-1901 in Combination with Anti-PD-1 Balstilimab in a Phase 2 Study in Primary Glioblastoma Patients
October 12, 2022
From
Agenus Inc.
Via
Globe NewsWire
12 Health Care Stocks Moving In Monday's After-Market Session
October 10, 2022
Via
Benzinga
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
October 07, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.